NEW YORK, Sept. 16 /PRNewswire/ — Reportlinker.com announces
that a new market research report is available in its
catalogue:

U.S. Market for Cardiac Rhythm Management, Electrophysiology and
Ablation Devices 2010

http://www.reportlinker.com/p0294050/US-Market-for-Cardiac-Rhythm-Management-Electrophysiology-and-Ablation-Devices-2010.html

In 2009, the U.S. market for cardiac rhythm management (CRM),
electrophysiology and ablation devices was valued at $7.63 billion.
This market includes

– Implantable Cardioverter-Defibrillators (ICDs)

– Pacemakers

– Cardiac Resynchronization Therapy devices (CRTs)

– Cardiac stimulation leads

– External defibrillators

– Ablation catheters

– Diagnostic electrophysiology (EP) catheters

– Intracardiac ultrasound (ICE) catheters

– Electrophysiology (EP) stimulators

– Cardiac monitoring devices

Over the forecast period, the CRM, electrophysiology and
ablation device market will be driven by the aging population, rise
in cardiac ablation procedures and adoption of advanced CRM
devices. Within the cardiac rhythm management, electrophysiology
and ablation markets, companies such as Boston Scientific, Biosense
Webster, Medtronic, Philips, St. Jude Medical and Zoll lead the
market, among many others.

This report provides a comprehensive and detailed analysis of
market revenues by device type, market forecasts through 2016, unit
sales, average selling prices, market drivers and limiters and a
detailed competitive analysis, including manufacturer market shares
and product portfolios.

The

‘/>”/>

SOURCE